Trials / Unknown
UnknownNCT01709461
Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical Trial
Continue Providing Care for Patient Who Participated in the Adagio TVP 1012/501 Clinical Trial
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (estimated)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
the purpose of the study is to extend the use of Rasagelin Mesylate 1mg per day by subjects who participated in the Adagio TVP 1012/501 according to form 4a for additional three years.
Conditions
Timeline
- Start date
- 2012-10-01
- First posted
- 2012-10-18
- Last updated
- 2012-10-18
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01709461. Inclusion in this directory is not an endorsement.